Lazard Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
|
|||||
|
2025
Q1 | $77K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $92K | Sell |
|
|||||
|
2024
Q2 | $237K | Buy |
|
|||||
|
2024
Q1 | $165K | Sell |
|
|||||
|
2023
Q4 | $4.94M | Sell |
|
|||||
|
2023
Q3 | $4.41M | Buy |
|
|||||
|
2023
Q2 | $1.01M | Sell |
|
|||||
|
2023
Q1 | $2.33M | Sell |
|
|||||
|
2022
Q4 | $4.39M | Buy |
|
|||||
|
2022
Q3 | $3.15M | Buy |
|
|||||
|
2022
Q2 | $544K | Buy |
|
|||||
|
2022
Q1 | $136K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $40K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $56K | Sell |
|
|||||
|
2020
Q4 | $754K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.27M | Buy |
|